Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
A Review of CancerSEEK
lungcanc
The Treatment of Patients with Oligometastatic Lung Cancer
lungcanc
The IASLC Provides More Than Just Scientific Knowledge at Tangier Conference
lungcanc
Antoinette Wozniak, MD
lungcanc
Raymond Osarogiagbon, MBBS, FACP
lungcanc
After the Consultation: Social Media, Inter-Patient Communication, and Clinical Trials
lungcanc
Dr. James D. Cox
lungcanc
Vassiliki A. Papadimitrakopoulou, MD
lungcanc
Dr. David J. Sugarbaker
lungcanc
EGFR TKIs: A Marathon or Sprint?
lungcanc
1
...
21
22
23
...
53
Page 22 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
